1 December, 2012: World Response to AIDS needs more vigor: article in the Financial Times announcing new Rush Foundation-funded research
Some of the world’s top economists have gotten together to take a new look at the HIV/AIDS epidemic and see whether money can be better spent. It’s called the RethinkHIV project and includes three Nobel Laureates. By Joe DeCapua
After a decade of unprecedented increases in donor funding and a corresponding 17% decline world-wide in the number of new infections, the fight against HIV is losing momentum. By Bjørn Lomborg and Peter Piot
Based on the first-ever comprehensive cost-benefit analysis of AIDS investments in sub-Saharan Africa, an Expert Panel of worldclass economists including three Nobel Laureates calls on policymakers to focus more resources on Vaccine Research to cut the delay in developing a life-saving vaccine.
In an environment of funding shortfalls and donor cutbacks, how can we ensure that the resources dedicated to the battle against HIV/AIDS produce the greatest bang for the buck?
New, actionable priorities on HIV/AIDS in Africa will be issued by an Expert Panel of worldclass economists, including three Nobel Laureates, on September 28 in Washington, DC.
COPENHAGEN – Thirty years ago, the world got its first inkling of impending catastrophe when five young gay men in Los Angeles were struck down by the illness that became known as HIV/AIDS. By Bjørn Lomborg